{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:05:41Z","timestamp":1794449141829,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2020\/SKK06\/SYUC\/01\/1"],"award-info":[{"award-number":["FRGS\/1\/2020\/SKK06\/SYUC\/01\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010798","name":"Sunway University","doi-asserted-by":"publisher","award":["EXT-SST-DBS-BWH-2018-01"],"award-info":[{"award-number":["EXT-SST-DBS-BWH-2018-01"]}],"id":[{"id":"10.13039\/501100010798","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010798","name":"Sunway University","doi-asserted-by":"publisher","award":["GRTIN-ECR-SBMDC-05-2024"],"award-info":[{"award-number":["GRTIN-ECR-SBMDC-05-2024"]}],"id":[{"id":"10.13039\/501100010798","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biopha.2024.116744","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T20:07:11Z","timestamp":1716926831000},"page":"116744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Adenovirus-mediated expression of MOAP-1, Bax and RASSF1A\u00a0antagonizes chemo-drug resistance of human breast cancer cells expressing cancer stem cell markers"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2106-1449","authenticated-orcid":false,"given":"Ee Wern","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar Daud Iskandar","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long Chiau","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chit Laa","family":"Poh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bey Hing","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze Pheng","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan Onn","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2024.116744_bib1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1091\/mbc.e13-07-0374","article-title":"Microtubule segment stabilization by RASSF1A is required for proper microtubule dynamics and Golgi integrity","volume":"25","author":"Arnette","year":"2014","journal-title":"Mol. Biol. Cell"},{"issue":"7","key":"10.1016\/j.biopha.2024.116744_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.cgt.7700473","article-title":"Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500","volume":"9","author":"Buller","year":"2002","journal-title":"Cancer Gene Ther."},{"issue":"3","key":"10.1016\/j.biopha.2024.116744_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6030077","article-title":"Breast cancer stem cells","volume":"6","author":"Crabtree","year":"2018","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.biopha.2024.116744_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4161\/bioa.20975","article-title":"The actin cytoskeleton as a sensor and mediator of apoptosis","volume":"2","author":"Desouza","year":"2012","journal-title":"BioArchitecture"},{"issue":"1","key":"10.1016\/j.biopha.2024.116744_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.22452\/jummec.vol24no1.6","article-title":"Mutation profile of breast cancer In Malaysian patients","volume":"24","author":"Farahnaz","year":"2021","journal-title":"JUMMEC"},{"issue":"14","key":"10.1016\/j.biopha.2024.116744_bib6","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1128\/MCB.02011-07","article-title":"Dynamics of RASSF1A\/MOAP-1 association with death receptors","volume":"28","author":"Foley","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"24","key":"10.1016\/j.biopha.2024.116744_bib7","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.1073\/pnas.0700007104","article-title":"Inhibition of ubiquitin-mediated degradation of MOAP-1 by apoptotic stimuli promotes Bax function in mitochondria","volume":"104","author":"Fu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.biopha.2024.116744_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jgm.2698","article-title":"Gene therapy clinical trials worldwide to 2012 - an update","volume":"15","author":"Ginn","year":"2013","journal-title":"J. Gene Med."},{"issue":"17","key":"10.1016\/j.biopha.2024.116744_bib9","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1128\/MCB.00117-06","article-title":"Actin-induced hyperactivation of the ras signaling pathway leads to apoptosis in Saccharomyces cerevisiae","volume":"26","author":"Gourlay","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2024.116744_bib10","article-title":"Heating it up: Oncolytic viruses make tumors \u2018hot\u2019 and suitable for checkpoint blockade immunotherapies","volume":"vol. 7","author":"Gujar","year":"2018"},{"issue":"2","key":"10.1016\/j.biopha.2024.116744_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10020246","article-title":"Cytokine-coding oncolytic adenovirus TILT-123 is safe, selective, and effective as a single agent and in combination with immune checkpoint inhibitor anti-PD-1","volume":"10","author":"Havunen","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116744_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01945","article-title":"Chimeric proteins containing MAP-1 and functional domains of C4b-binding protein reveal strong complement inhibitory capacities","volume":"9","author":"Hertz","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116744_bib13","first-page":"22","article-title":"K-ras peptide mimotope induces a humoral immune response against G12V K-ras antigen in BALB\/c mice","volume":"28","author":"Hoo","year":"2020","journal-title":"AsPac J. Mol. Biol. Biotechnol."},{"key":"10.1016\/j.biopha.2024.116744_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-43624-1_7","article-title":"The role of DNA methylation in cancer","volume":"945","author":"Lakshminarasimhan","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"40","key":"10.1016\/j.biopha.2024.116744_bib15","doi-asserted-by":"crossref","first-page":"24100","DOI":"10.1074\/jbc.M115.648345","article-title":"Modulator of apoptosis 1 (MOAP-1) is a tumor suppressor protein linked to the RASSF1A protein","volume":"290","author":"Law","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116744_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/536802","article-title":"Modulator of Apoptosis 1: A Highly Regulated RASSF1A-Interacting BH3-Like Protein","volume":"2012","author":"Law","year":"2012","journal-title":"Mol. Biol. Int."},{"issue":"7","key":"10.1016\/j.biopha.2024.116744_bib17","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00432-020-03231-9","article-title":"Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1","volume":"146","author":"Lee","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116744_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/21.3.485","article-title":"Apoptosis in cancer","volume":"21","author":"Lowe","year":"2000","journal-title":"Carcinogenesis"},{"issue":"22","key":"10.1016\/j.biopha.2024.116744_bib19","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/jnci\/djh305","article-title":"Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs","volume":"96","author":"Luciani","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"issue":"14","key":"10.1016\/j.biopha.2024.116744_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143526","article-title":"Cancer-associated fibroblasts: implications for cancer therapy","volume":"13","author":"Maia","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.116744_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cellsig.2018.01.022","article-title":"PNMA family: Protein interaction network and cell signalling pathways implicated in cancer and apoptosis","volume":"45","author":"Pang","year":"2018","journal-title":"Cell. Signal."},{"issue":"21","key":"10.1016\/j.biopha.2024.116744_bib22","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.1158\/1078-0432.CCR-08-0483","article-title":"A phase 1 open-label, accelerated dose-escalation study of the hypoxia-activated prodrug AQ4N in patients with advanced malignancies","volume":"14","author":"Papadopoulos","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116744_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-9-209","article-title":"Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy","volume":"9","author":"Pham","year":"2011","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.biopha.2024.116744_bib24","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-07-5575","article-title":"Bicarbonate increases tumor pH and inhibits spontaneous metastases","volume":"69","author":"Robey","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2024.116744_bib25","article-title":"New synthetic phenylquinazoline derivatives induce apoptosis by targeting the pro-survival members of the BCL-2 family","volume":"67","author":"Samson","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2024.116744_bib26","article-title":"Alpha-mangostin activates MOAP-1 tumor suppressor and mitochondrial signaling in MCF-7 human breast cancer cells","volume":"2022","author":"Samson","year":"2022","journal-title":"Evid. - Based Complement. Altern. Med."},{"issue":"2","key":"10.1016\/j.biopha.2024.116744_bib27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1242\/jcs.02741","article-title":"CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells","volume":"119","author":"Schabath","year":"2006","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116744_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines9030195","article-title":"K-ras peptide mimotope induces antigen specific Th1 and B-cell immune responses against G12A-mutated K-Ras antigen in balb\/c mice","volume":"9","author":"Siak","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2024.116744_bib29","article-title":"Revealing the roles of MOAP1 in diseases: a review","volume":"Vol. 11","author":"Su","year":"2022"},{"key":"10.1016\/j.biopha.2024.116744_bib30","article-title":"The role of Epstein\u2013Barr virus in nasopharyngeal carcinoma","volume":"vol. 14","author":"Su","year":"2023"},{"key":"10.1016\/j.biopha.2024.116744_bib31","article-title":"Engineered oncolytic adenoviruses: an emerging approach for cancer therapy","volume":"vol. 11","author":"Tan","year":"2022"},{"issue":"41","key":"10.1016\/j.biopha.2024.116744_bib32","doi-asserted-by":"crossref","first-page":"14623","DOI":"10.1073\/pnas.0503524102","article-title":"MAP-1 is a mitochondrial effector of Bax","volume":"102","author":"Tan","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.biopha.2024.116744_bib33","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1158\/0008-5472.CAN-16-1577","article-title":"Armed oncolytic adenovirus-expressing PD-L1 mini-body enhances antitumor effects of chimeric antigen receptor T cells in solid tumors","volume":"77","author":"Tanoue","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116744_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1517\/14728222.2013.733001","article-title":"Targeting the Bcl-2 family for cancer therapy","volume":"17","author":"Thomas","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"issue":"8","key":"10.1016\/j.biopha.2024.116744_bib35","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1074\/jbc.M512128200","article-title":"The RASSF1A tumor suppressor activates bax via MOAP-1","volume":"281","author":"Vos","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2024.116744_bib36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/02841860601156157","article-title":"Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model","volume":"46","author":"Watson","year":"2007","journal-title":"Acta Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116744_bib37","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1158\/1078-0432.CCR-10-3425","article-title":"Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignancies","volume":"17","author":"Weiss","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.biopha.2024.116744_bib38","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.2174\/1568026619666190904163524","article-title":"Overview of current immunotherapies targeting mutated KRAS cancers","volume":"19","author":"Winfrey Pui Yee","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2024.116744_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ph15091075","article-title":"Combination of Talazoparib and calcitriol enhanced anticancer effect in triple-negative breast cancer cell lines","volume":"15","author":"Wong","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.biopha.2024.116744_bib40","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bbamcr.2006.07.001","article-title":"Regulation of the actin cytoskeleton in cancer cell migration and invasion","volume":"1773","author":"Yamaguchi","year":"2007","journal-title":"Biochim. Et. Biophys. Acta - Mol. Cell Res."},{"issue":"12","key":"10.1016\/j.biopha.2024.116744_bib41","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.biocel.2012.08.022","article-title":"Cancer stem cells","volume":"44","author":"Yu","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2024.116744_bib42","article-title":"Oncolytic Adenovirus: Prospects for Cancer Immunotherapy","volume":"vol. 12","author":"Zhao","year":"2021"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224006280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224006280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:58:03Z","timestamp":1781650683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224006280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":42,"alternative-id":["S0753332224006280"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116744","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus-mediated expression of MOAP-1, Bax and RASSF1A\u00a0antagonizes chemo-drug resistance of human breast cancer cells expressing cancer stem cell markers","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116744"}}